Societe Generale’s Allergan plc AGN Stock Holding History

Societe Generale’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.38M	Buy	+10,315	New	+$2.38M	0.02%	750

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Societe Generale's AGN Position: Q2 2016 in Review

Societe Generale opened a new position in Allergan plc (AGN) in Q2 2016: 10,315 shares worth $2.38M. The stake represents 0.02% of the portfolio and ranks #750 among its holdings.

1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Societe Generale held 10,315 shares of Allergan plc worth $2.38M as of Q2 2016.
Allergan plc was a new Societe Generale position in Q2 2016.
Allergan plc made up 0.02% of Societe Generale's portfolio in Q2 2016, its #750 holding.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.